News About: Pharm. Affairs
Most incrementally modified drugs approved last year were antihypertensives with 7 products
Just like new drugs, incrementally modified drugs that are being developed by Korean pharmaceutical companies are also experiencing a drought as well.
According to the Ministry of Food and Drug Safety, there were 11 ...
“Pharmacies with less than 5 employees must follow rules about minimum wage and retirement pension”
It was requested to definitely follow the minimum wage, holiday benefits and retirement pension not to cause any trouble in pharmacies with less than 5 employees.
It was also stressed it would be important to fully u...
Pouring generic approval of ‘Dexid Tab’ generics, will enlarge market of diabetic neuropathy therapies?
Dexid Tab, a diabetic neuropathy therapy, were reportedly referenced by more than 40 generic drugs to acquire approval.
The market size of Dexid Tab is calculated at approximately KRW 10 billion, but it seems it will...
Celltrion proves equivalent effect on Remsima, Remicade and Humira
At the 2018 European Crohn’s and Colitis Organisastion(ECCO) held in Vienna, Austria, large clinical study results on Crohn’s disease patients were revealed.
In these studies, the remission rate of each patient group...
KPA welcomes exclusion of expenses for antismoking therapies from income tax withholdings
The Korea Pharmaceutical Association(President Chan-Hwi Cho) has welcomed to the Ministry of Strategy and Finance’s pre-announcement of the Partial Revision Bill to the Income Tax Law enforcement ordinance which exclu...
Powders and granules added to subject to bioequivalence test
Powders and granules will be added to subject to drug equivalence test, which has only been applied to tablets, capsules and suppositories.
Under the Partial Revision Bill to the ‘Regulations about Drug Safety’ which...
PharmPay officially launches ‘Alipay’ payment service only for pharmacies
Alipay, a global online and mobile payment platform operated by Ant Financial Services Group, a subsidiary of Alibaba Group, will now be available to use in pharmacies through CreSoty(PharmPay), a company specializing...
LegoChem Bio’s Phase II clinical trial of ‘Super Antibody’ designated for accelerated approval by FDA
LegoChem Biosciences(LegoChem Bio) officially announced that Delpazloid(LCB01-0371), a Phase II clinical trial pipeline, was designated as a medicine for the Fast Track process by the U.S. Food and Drug Administration...
“It is inadequate for government to take expenses for return of mis/unused medicines”
In response to the Korea Pharmaceutical Association’s(KPA) opinion to obligate return of mis/unused medicines, the Ministry of Health and Welfare(MOHW) answered that it was inadequate.
The MOHW revealed the ‘Stance t...
Insults on Korean new drugs, 4 of 29 approval drugs suspended in manufacturing
Starting SK Chemicals’ ‘Sunpla Inj’ in 1999, the total 29 Korean new drugs have been approved, but 4 of them were thrown out from the market for reasons, such as poor sales.
According to the Ministry of Food and Drug...
